Iambic to Participate in March Investor Conferences
Iambic official newsroom · Indexed industry source record · Source published: Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:09:23 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
SAN DIEGO, CA – March 2, 2026 -- Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven drug discovery platform, today announced its participation in upcoming March investor conferences: Leerink Partners Global Healthcare Conference: March 9-12 Jefferies Biotech Summit: March 10-11 KeyBanc Healthcare Forum: March 18-19 About Iambic Iambic is a c
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.